Graham K. Cooper - 12 May 2022 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Issuer symbol
KZR
Transactions as of
12 May 2022
Net transactions value
$0
Form type
4
Filing time
13 May 2022, 17:04:17 UTC
Previous filing
31 Jan 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Stock Option (right to buy) Award $0 +26,000 $0.000000 26,000 12 May 2022 Common Stock 26,000 $5.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth (1/36th) of the shares shall vest on a monthly basis commencing on May 12, 2022, subject to the Reporting Person continuing to provide service through each such date.